Non‐serious adverse events: serum transaminases elevation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: serum transaminases elevation compared with TACE (very low certainty).
1 finding from 1 review
Non‐serious adverse events: total bilirubin elevation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: total bilirubin elevation compared with TACE (very low certainty).
1 finding from 1 review
Proportion of participants without serum AFP normalisation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes proportion of participants without serum AFP normalisation compared with TACE (very low certainty).
1 finding from 1 review
Motor outcome at school age (Griffiths Locomotor, MABC) · preterm infants
2 findings from 1 review
Depressive symptomatology (lower = less depressive symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Anxious symptomatology (lower = less anxious symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Intervention not reported
Duloxetine low dose RCTs: 6 Participants: 1104 · people with chronic pain Interventions: duloxetine low dose (< 60 mg), standard dose (60 mg), and high dose (> 60 mg); milnacipran…
1 finding from 1 review
no estimate extracted
6 participants
Moderate
Intervention not reported
Duloxetine low dose RCTs: 6 Participants: 1031 · people with chronic pain Interventions: amitriptyline standard dose (25‐75 mg); desvenlafaxine high dose (> 50 mg); duloxetine low dose (<…
1 finding from 1 review
no estimate extracted
6 participants
Very low
Intervention not reported
Duloxetine low dose RCTs: 6 Participants: 1116 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
6 participants
Moderate
Proportion of participants requiring further IOP‐lowering interventions (additional surgery, medications, or both) (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants requiring further IOP‐lowering… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more recurrent APAC episodes in the same eye (lower number of events is better) · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
It is very uncertain whether phacoemulsification changes proportion of participants with 1 or more recurrent APAC episodes in… compared with laser peripheral iridotomy (very low certainty).
1 finding from 1 review
Mean number of antiglaucoma medications at 1‐year · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Mean IOP ( · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Limitation of chewing or swallowing · Adults (>18 years) with established dry socket following permanent tooth extraction
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
TUG (lower score = faster) · adults following hip fracture surgery
The intervention showed no clear difference in TUG (lower score = faster) (low certainty).
1 finding from 1 review
Intervention not reported
TUG (lower score = faster) · adults following hip fracture surgery
It is very uncertain whether the intervention changes TUG (lower score = faster) (very low certainty).
1 finding from 1 review
Adverse events (pain and swelling at injection site and limitation of elbow movement following injection) · lateral elbow pain
Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).
1 finding from 1 review
Live birth rate · couples undergoing embryo transfer
High probably leads to higher live birth rate ‐ high vs low or no hyaluronic acid compared with low or no hyaluronic acid (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · couples undergoing embryo transfer
High probably leads to higher clinical pregnancy rate ‐ high vs low or no hyaluronic acid compared with low or no hyaluronic acid (moderate certainty).
1 finding from 1 review
Secondary outcome measure: lower extremity function at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found